Suppr超能文献

一种阿育吠陀配方(GlucoCare胶囊)在非胰岛素依赖型糖尿病中的双盲、安慰剂对照临床评估。

Double-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus.

作者信息

Sharma R K, Patki Pralhad S

机构信息

Department of Dravyaguna and Rasashastra, Government Ayurvedic College, Guwahati, Assam, India.

出版信息

J Ayurveda Integr Med. 2010 Jan;1(1):45-51. doi: 10.4103/0975-9476.59827.

Abstract

Diabetes mellitus describes a metabolic disorder of multiple etiologies characterized by insulin resistance, relative insulin deficiency and hyperglycemia with disturbances of carbohydrate, fat and protein metabolism. The goal for treatment of diabetes is to prevent its acute manifestations and long-term microvascular and macrovascular complications. The present study was conducted to evaluate the efficacy and safety of an Ayurvedic formulation (GlucoCare Capsules) in non-insulin dependent diabetes mellitus. Fifty NIDDM patients of pitta-kapha prakriti attending the outpatient department of the Government Ayurvedic Medical College, Guwahati, Assam, India were included in the study, and randomly divided into 2 groups, GlucoCare and placebo. All received either GlucoCare or placebo in a dose of 2 capsules twice daily, before meals for 3 months. All 50 patients completed the study - no drop outs, withdrawals or patients lost to follow up. The GlucoCare group showed significant improvement in symptoms from the 2(nd) month till the end of the study. GlucoCare was well tolerated by all patients throughout the treatment period with no evidence of adverse effects. The study indicates clinical efficacy of GlucoCare Capsules in the management of NIDDM in those belonging to pitta-kapha prakriti. The formulation is well tolerated and appears safe in the dosage used.

摘要

糖尿病是一种由多种病因引起的代谢紊乱疾病,其特征为胰岛素抵抗、相对胰岛素缺乏以及碳水化合物、脂肪和蛋白质代谢紊乱导致的高血糖。糖尿病的治疗目标是预防其急性表现以及长期的微血管和大血管并发症。本研究旨在评估一种阿育吠陀制剂(葡糖康胶囊)治疗非胰岛素依赖型糖尿病的疗效和安全性。印度阿萨姆邦古瓦哈蒂政府阿育吠陀医学院门诊部的50名皮塔-卡法体质的非胰岛素依赖型糖尿病患者被纳入研究,并随机分为两组,即葡糖康组和安慰剂组。所有患者均每日两次、每次2粒胶囊,于饭前服用葡糖康或安慰剂,持续3个月。所有50名患者均完成了研究,无退出、脱落或失访情况。葡糖康组从第2个月直至研究结束症状均有显著改善。在整个治疗期间,所有患者对葡糖康耐受性良好,未出现不良反应。该研究表明,葡糖康胶囊对皮塔-卡法体质的非胰岛素依赖型糖尿病患者具有临床疗效。该制剂耐受性良好,在所使用的剂量下似乎是安全的。

相似文献

引用本文的文献

5
Foundational principles of classical Ayurveda research.古典阿育吠陀研究的基本原理。
J Ayurveda Integr Med. 2013 Oct;4(4):198-205. doi: 10.4103/0975-9476.123688.

本文引用的文献

3
Thiazolidinediones: do harms outweigh benefits?噻唑烷二酮类药物:危害大于益处吗?
CMAJ. 2009 Jan 6;180(1):16-7. doi: 10.1503/cmaj.081713. Epub 2008 Dec 10.
6
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验